AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 83 filers reported holding AMYLYX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,930,984 | -48.7% | 1,197,760 | -39.5% | 0.04% | -47.0% |
| Q2 2023 | $42,712,483 | +27.8% | 1,980,180 | +73.8% | 0.08% | +16.9% |
| Q1 2023 | $33,425,302 | +248.2% | 1,139,240 | +234.0% | 0.07% | +238.1% |
| Q3 2022 | $9,600,000 | -24.3% | 341,064 | -48.2% | 0.02% | -19.2% |
| Q2 2022 | $12,680,000 | +68.8% | 658,373 | +12.6% | 0.03% | +85.7% |
| Q1 2022 | $7,510,000 | – | 584,464 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpha Wave Global, LP | 930,337 | $27,296,088 | 10.08% |
| Perceptive Advisors | 6,034,644 | $177,056,455 | 5.23% |
| GREAT POINT PARTNERS LLC | 783,795 | $22,996,545 | 4.52% |
| Ghost Tree Capital, LLC | 475,000 | $13,937,000 | 4.12% |
| Altium Capital Management LP | 185,000 | $5,427,900 | 3.01% |
| Boxer Capital, LLC | 2,084,000 | $61,145 | 3.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 789,591 | $23,166,600 | 1.37% |
| EMERALD ADVISERS, LLC | 972,835 | $28,542,979 | 1.37% |
| SECTORAL ASSET MANAGEMENT INC | 242,400 | $7,112,016 | 1.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,984,333 | $58,220,330 | 1.30% |